The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

KOS AI Argus KOS AI, a Silicon Valley health technology firm, has developed a non-invasive glucose monitoring device t ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

Now at 32, he continues to live with the condition while endorsing advancements in diabetes care, particularly the Dexcom G7 glucose monitoring system ... is a type of wearable technology that ...

For people between the ages 2 to 18, Dexcom G7 remains the most accurate 2 continuous glucose monitoring system ... proud to offer the longest lasting wearable and most accurate CGM, giving ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

“By listening to the needs of our users, we’re proud to offer the longest lasting wearable and most accurate CGM, giving people the knowledge to better control their diabetes with our best-in ...

Rising concerns over the escalating prevalence of diabetes worldwide are fueling the demand for efficient glucose monitoring systems. Factors contributing ... In February 2024, Know Labs introduced a ...

Abbott is already a big player in the wearable ... glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...